Biological characteristics of CD133+ cells in nasopharyngeal carcinoma

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 57-63

  Zhuang, Hui Wen ^a   Mo, Ting Ting ^a   Hou, Wei Jian ^a   Xiong, Guan Xia ^a   Zhu, Xiao Lin ^a   Fu, Qing Ling ^a   Wen, Wei Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cancer stem cells; CD133; Nasopharyngeal carcinoma

Indexed keywords

CD133 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; GLYCOPROTEINS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MICE, INBRED BALB C; NASOPHARYNGEAL NEOPLASMS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PEPTIDES; SOXB1 TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878180209     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2408     Document Type: Article

References (27)

1. Marotta LL and Polyak K: Cancer stem cells: a model in the making. Curr Opin Genet Dev 19: 44-50, 2009.
2. Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737, 1997. (Pubitemid 27298715)
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003. (Pubitemid 36418143)
4. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003. (Pubitemid 37187480)
5. Fang D, Nguyen TK, Leishear K, et al: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337, 2005. (Pubitemid 41508000)
6. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951, 2005. (Pubitemid 41713363)
7. Li C, Heidt DG, Dalerba P, et al: Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037, 2007.
8. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110, 2007. (Pubitemid 46067310)
9. + ovarian cancer cells. Oncogene 28: 209-218, 2009.
10. Ma S, Chan KW, Hu L, et al: Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132: 2542-2556, 2007. (Pubitemid 46890873)
11. Kim CF, Jackson EL, Woolfenden AE, et al: Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835, 2005. (Pubitemid 40806415)
12. Shmelkov SV, St Clair R, Lyden D and Rafii S: AC133/CD133/Prominin-1. Int J Biochem Cell Biol 37: 715-719, 2005. (Pubitemid 40202993)
13. Klonisch T, Wiechec E, Hombach-Klonisch S, et al: Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med 14: 450-460, 2008.
14. Galli R, Binda E, Orfanelli U, et al: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004. (Pubitemid 39331011)
15. Bao S, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006. (Pubitemid 44949604)
16. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ and Collins AT: CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117: 3539-3545, 2004. (Pubitemid 39206394)
17. Yin S, Li J, Hu C, Chen X, et al: CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 120: 1444-1450, 2007. (Pubitemid 46355378)
18. Frank NY, Margaryan A, Huang Y, et al: ABCG5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65: 4320-4333, 2005. (Pubitemid 40775671)
19. Hermann PC, Huber SL, Herrler T, et al: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323, 2007. (Pubitemid 47355323)
20. + cancer stem cells in human solid tumours. PLoS One 3: e3469, 2008.
21. Wang J, Guo LP, Chen LZ, Zeng YX and Lu SH: Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 67: 3716-3724, 2007. (Pubitemid 46762157)
22. Zhang HB, Ren CP, Yang XY, et al: Identification of label-retaining cells in nasopharyngeal epithelia and nasopharyngeal carcinoma tissues. Histochem Cell Biol 127: 347-354, 2007.
23. Huang EH, Heidt DG, Li CW and Simeone DM: Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance. Surgery 141: 415-419, 2007. (Pubitemid 46441320)
24. Soltysova A, Altanerova V and Altaner C: Cancer stem cells. Neoplasma 52: 435-440, 2005. (Pubitemid 41809399)
25. Li L and Neaves WB: Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66: 4553-4557, 2006.
26. Postovit LM, Margaryan NV, Seftor EA, et al: Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 105: 4329-4334, 2008. (Pubitemid 351754380)
27. Wei XD, Zhou L, Cheng L, Tian J, Jiang JJ and Maccallum J: In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line. Head Neck 31: 94-101, 2009.